ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
Background ACE angioedema has not been characterized in comparison with angioedema from other causes in acute hospitalized patients. Methods We retrospectively compared ACE-angioedema and non-ACE angioedema patients from January 2013 to May 2017. Results Of 855 cases screened, 575 met the inclusion...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2020-01-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2020.1711641 |
_version_ | 1828077958932201472 |
---|---|
author | David S. Weisman Nelly Arnouk M. Bilal Asghar M. Raheel Qureshi Anagha Kumar Sameer Desale Lyn Camire Stephen Pineda |
author_facet | David S. Weisman Nelly Arnouk M. Bilal Asghar M. Raheel Qureshi Anagha Kumar Sameer Desale Lyn Camire Stephen Pineda |
author_sort | David S. Weisman |
collection | DOAJ |
description | Background ACE angioedema has not been characterized in comparison with angioedema from other causes in acute hospitalized patients. Methods We retrospectively compared ACE-angioedema and non-ACE angioedema patients from January 2013 to May 2017. Results Of 855 cases screened, 575 met the inclusion criteria of angioedema diagnosis and an electronic medical record. Of these, 297 (51.7%) had ACE angioedema and 278 had angioedema from other causes, of these 31 who were taking an ACE inhibitor that was not considered to be the cause of angioedema (ACE other cause). At least 80% of cases in all groups were African American. Epinephrine was prescribed in 21% of ACE angioedema cases. One-third of patients in all groups were admitted to the ICU, and about 25% required intubation. Previous history of ACE inhibitor-induced angioedema was found in 63 of 278 non-ACE cause angioedema patients (23%) and in 23 (8%) in the ACE cause group. Conclusion ACE angioedema was the cause of half of angioedema admissions over a 4.5-year period. Mortality, morbidity, and treatment did not differ between the groups. Patients on ACE inhibitors were often treated with medications known not to be effective for ACE angioedema. Over one-fourth of patients not taking an ACE inhibitor had a previous history of ACE angioedema, and 31 patients taking ACE inhibitors were diagnosed with non-ACE angioedema. Regardless of the etiology of angioedema, 25% of patients required airway protection in the form of intubation. |
first_indexed | 2024-04-11T02:38:57Z |
format | Article |
id | doaj.art-69c8510dbbf846f9b9138b7fbbb66e32 |
institution | Directory Open Access Journal |
issn | 2000-9666 |
language | English |
last_indexed | 2024-04-11T02:38:57Z |
publishDate | 2020-01-01 |
publisher | Greater Baltimore Medical Center |
record_format | Article |
series | Journal of Community Hospital Internal Medicine Perspectives |
spelling | doaj.art-69c8510dbbf846f9b9138b7fbbb66e322023-01-02T19:25:53ZengGreater Baltimore Medical CenterJournal of Community Hospital Internal Medicine Perspectives2000-96662020-01-01101161810.1080/20009666.2020.17116411711641ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patientsDavid S. Weisman0Nelly Arnouk1M. Bilal Asghar2M. Raheel Qureshi3Anagha Kumar4Sameer Desale5Lyn Camire6Stephen Pineda7MedStar Good Samaritan HospitalMedStar Good Samaritan HospitalMedStar Good Samaritan HospitalMedStar Good Samaritan HospitalMedStar Health Research InstituteMedStar Health Research InstituteMedStar Good Samaritan HospitalMedStar Good Samaritan HospitalBackground ACE angioedema has not been characterized in comparison with angioedema from other causes in acute hospitalized patients. Methods We retrospectively compared ACE-angioedema and non-ACE angioedema patients from January 2013 to May 2017. Results Of 855 cases screened, 575 met the inclusion criteria of angioedema diagnosis and an electronic medical record. Of these, 297 (51.7%) had ACE angioedema and 278 had angioedema from other causes, of these 31 who were taking an ACE inhibitor that was not considered to be the cause of angioedema (ACE other cause). At least 80% of cases in all groups were African American. Epinephrine was prescribed in 21% of ACE angioedema cases. One-third of patients in all groups were admitted to the ICU, and about 25% required intubation. Previous history of ACE inhibitor-induced angioedema was found in 63 of 278 non-ACE cause angioedema patients (23%) and in 23 (8%) in the ACE cause group. Conclusion ACE angioedema was the cause of half of angioedema admissions over a 4.5-year period. Mortality, morbidity, and treatment did not differ between the groups. Patients on ACE inhibitors were often treated with medications known not to be effective for ACE angioedema. Over one-fourth of patients not taking an ACE inhibitor had a previous history of ACE angioedema, and 31 patients taking ACE inhibitors were diagnosed with non-ACE angioedema. Regardless of the etiology of angioedema, 25% of patients required airway protection in the form of intubation.http://dx.doi.org/10.1080/20009666.2020.1711641angioedemaangiotensin-converting enzyme inhibitorace inhibitorangiotensin receptor blockerarb |
spellingShingle | David S. Weisman Nelly Arnouk M. Bilal Asghar M. Raheel Qureshi Anagha Kumar Sameer Desale Lyn Camire Stephen Pineda ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients Journal of Community Hospital Internal Medicine Perspectives angioedema angiotensin-converting enzyme inhibitor ace inhibitor angiotensin receptor blocker arb |
title | ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients |
title_full | ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients |
title_fullStr | ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients |
title_full_unstemmed | ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients |
title_short | ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients |
title_sort | ace inhibitor angioedema characterization and treatment versus non ace angioedema in acute hospitalized patients |
topic | angioedema angiotensin-converting enzyme inhibitor ace inhibitor angiotensin receptor blocker arb |
url | http://dx.doi.org/10.1080/20009666.2020.1711641 |
work_keys_str_mv | AT davidsweisman aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients AT nellyarnouk aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients AT mbilalasghar aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients AT mraheelqureshi aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients AT anaghakumar aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients AT sameerdesale aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients AT lyncamire aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients AT stephenpineda aceinhibitorangioedemacharacterizationandtreatmentversusnonaceangioedemainacutehospitalizedpatients |